Measuring visual function and quality of life in patients with cytomegalovirus retinitis: Development of a questionnaire

Archives of Ophthalmology

Volumn 114, Issue 7, 1996, Pages 841-847

  Wu, Albert W ^a,b   Coleson, Laura C ^b   Holbrook, Janet ^a   Jabs, Douglas A ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHESIS; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RETINITIS; VISUAL ACUITY;

EID: 0029897052     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140055008     Document Type: Article

References (48)

1. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of the Pneumocystis prophylaxis. N Engl J Med. 1993;329:1922-1926.
2. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:75-80.
3. Genensky SM. Acuity measurements - do they indicate how well a partially sighted person functions or could function? Am J Optom Physiol Opt. 1976;53:809-812.
4. Elliot DB, Hurst MA, Weatherill J. Comparing clinical tests of visual function in cataract with the patient's perceived visual disability. Eye. 1990;4:712-717.
5. Bernth-Petersen P. Visual functioning in cataract patients: methods of measuring and results. Acta Ophthalmol. 1981;59:198-205.
6. Javitt JC, Brenner MH, Curbow B, Legro MW, Street DA. Outcomes of cataract surgery. Arch Ophthalmol. 1993;111:686-691.
7. Mangione CM, Phillips RS, Seddon JM, et al. Development of the Activities of Daily Vision Scale. Med Care. 1992;30:1111-1126.
8. Brenner MH, Curbow B, Javitt J, Legro MW, Sommer A. Vision change and quality of life in the elderly. Arch Ophthalmol. 1992;111:680-685.
9. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112:630-638.
10. User's Manual: Cataract Type Specification. Bloomington, Minn: Health Outcomes Institute; 1993.
11. Applegate WB, Miller ST, Elam JT, Freeman JM, Wood TO, Gettlefinger TC. Impact of cataract surgery with lens implantation on vision and physical function in elderly patients. JAMA. 1987;257:1064-1066.
12. Kleiner RC, Enger C, Alexander MF, Fine SL. Contrast sensitivity in age related macular degeneration. Arch Ophthalmol. 1988;106:55-57.
13. Ball K, Owsley C. The useful field of view test: a new technique for evaluating age-related declines in visual function. J Am Optom Assoc. 1993;64:71-79.
14. Ferguson BA, Buxton MJ, Drummond MF. Measuring and valuing health states related to visual impairment: a review of the literature, concepts, and methods. In: Drummond MF, ed. Measuring the Quality of Life of People With Visual Impairment: Proceedings of a Workshop. Washington, DC: US Dept of Health and Human Services; 1990:69-92. National Institutes of Health publication 903078.
15. Scott IU, Schein OD, West S, Bandeen-Roche K, Enger C, Folstein MF. Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol. 1993;112:329-335.
16. Babbie ER. The Practice of Social Research. 4th ed. Belmont, Calif: Wadsworth Publishing Co; 1986:265.
17. National Center for Health Statistics. Current Estimates From the Health Interview Survey: United States, 1968. Washington, DC: National Center for Health Statistics; 1970. Public Health Service publication 1000, series 10, No. 63.
18. Stewart AL, Hays RD, Ware JE. The MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Care. 1988;26:724-735.
19. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473-483.
20. Rubin HR, Wu AW, Gutierrez M, Liriano O, Safrin S. Reliability and validity of English and Spanish versions of a quality of life instrument for acute Pneumocystis carinii pneumonia. Read before the VIII International Conference on AIDS, July 20-23, 1992, Amsterdam, the Netherlands.
21. The Diabetic Retinopathy Study Research Group. Designs, methods, and baseline and results: DRS report #6. Invest Ophthalmol Vis Sci. 1981;21(1, 2):149-209.
22. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
23. Ferris FL III, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol. 1982;94:97-98.
24. Bailey IL, Lobie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53:740-745.
25. Studies of the Ocular Complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Studies of the Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: rationale, design, and methods. Controlled Clin Trials. 1992;13:22-39.
26. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297.
27. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
28. Sullivan P, Caldwell G, Alexander N, Kohner E. Long term outcome after photocoagulation for proliferative diabetic retinopathy. Diabet Med. 1990;7:788-794.
29. Spellman DC, Alexander KR, Fishman GA, Derlack DJ. Letter contrast sensitivity in retinitis pigmentosa patients assessed by Regan charts. Retina. 1989; 9:287-291.
30. Bernth-Petersen P. Outcome of cataract surgery, II: visual functioning in aphakic patients. Acta Ophthalmol. 1982;60:243-251.
31. Bernth-Petersen P. Cataract surgery. Acta Ophthalmol Suppl. 1985;174:9-47.
32. Gardner MJ, Altman DG. Statistics With Confidence: Confidence Intervals and Statistical Guidelines. London, England: British Medical Journal; 1989:46.
33. Karnofsky DA, Abelman WH, Craver LF, Burcheneal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1948;1:634-656.
34. Nunnally JC. Psychometric Theory. New York, NY: McGraw-Hill International Book Co; 1978;245.
35. Helmstater GC. Principles of Psychological Measurement. New York, NY: Appleton-Century-Crofts; 1964.
36. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease specific quality of life in clinical trials. Can Med Assoc J. 1986;134:889-895.
37. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217-S233.
38. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Med Care. 1991;29:786-798.
39. Wu AW, Rubin HR, Mathews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early AIDS-related complex. J Acquir Immune Defic Syndr. 1993;6:452-458.
40. Wu AW, Lichter SL, Richardson W, et al. Quality of life in patients receiving clarithromycin for Mycobacterium avium complex (MAC) infection and AIDS. Read before the VIII International Conference on AIDS, July 20-23, 1992, Amsterdam, the Netherlands.
41. Burgess A, Catalan J, Deyer M, et al. The reliability and validity of two HIV-specific health-related quality of life measures. AIDS. 1993;7:1001-1008.
42. Ganz PA, Schag CAC, Kahn B, Petersen L. Assessing the quality of life of HIV infected persons. Psychol Health. 1994;9:93-110.
43. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med. 1992;116:129-137.
44. Bozzette SA, Hays RD, Berry SH, Knaouse DE, Wu AW. Derivation and properties of a brief health-related quality-of-life assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr. 1995;8:253-265.
45. Lubeck DP, Fries JE. Health status among persons infected with human immunodeficiency virus: a community based study. Med Care. 1993;31:3.
46. Ware JE. Scales for measuring general health perceptions. Health Serv Res. 1976;11:396-415.
47. Croog SH, Levine S. Quality of life and health care interventions. In: Freeman HE, Levine S, eds. Handbook of Medical Sociology. 4th ed. Englewood Cliffs, NJ: Prentice-Hall International Inc; 1989:508-528.
48. Brislin RW. Back-translation for cross-cultural research. J Cross Cult Psychol. 1970;1:185-216.